Interestingly, a recent study reported that 12 months after infection, patients with mild COVID-19 had higher autoantibody levels to cytokines such as CCL21, CXCL13, and CXCL16, compared to long COVID-19 patients39. This evidence concerns the gene CXCL13 and infection.